The qRT-PCR analysis demonstrated at the mRNA level that HCQ treatment significantly reduced the expression of TLR9, CD44, OCT4, and KLF4 in HCC cells (Figure 3E). This evidence concerns the gene KLF4 and hepatocellular carcinoma.